During the past decade, Prairie Education and Research Cooperative conducted 42 clinical trials. In the 10-year time frame, 42 clinical trials started and 30 clinical trials were completed, i.e. on average, 71.4% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 20 clinical trials were completed. i.e. 153.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Prairie Education and Research Cooperative" #1 sponsor was "Abbott Medical Devices" with 10 trials, followed by "Edwards Lifesciences" with 9 trials sponsored, "Medtronic Cardiac Rhythm and Heart Failure" with 6 trials sponsored, "Eli Lilly and Company" with 5 trials sponsored and "Boston Scientific Corporation" with 5 trials sponsored. Other sponsors include 22 different institutions and companies that sponsored additional 28 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Prairie Education and Research Cooperative" #1 collaborator was "Massachusetts General Hospital" with 2 trials as a collaborator, "Merck KGaA, Darmstadt, Germany" with 2 trials as a collaborator, "The Cleveland Clinic" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator and "American College of Cardiology" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Prairie Education and Research Cooperative" are "Atrial Fibrillation" (5 trials), "Aortic Stenosis" (4 trials), "Heart Failure" (4 trials), "Peripheral Arterial Disease" (4 trials) and "Symptomatic Severe Aortic Stenosis" (3 trials). Many other conditions were trialed in "Prairie Education and Research Cooperative" in a lesser frequency.

Most popular intervention types in "Prairie Education and Research Cooperative" are "Device" (46 trials), "Drug" (14 trials), "Other" (3 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Insulin Lispro" (3 trials), "Cladribine Tablets" (2 trials), "ClosureFast Radiofrequency Ablation (RFA)" (2 trials), "Insulin Degludec" (2 trials) and "Insulin Glargine" (2 trials). Other intervention names were less common.

The vast majority of trials in "Prairie Education and Research Cooperative" are 60 trials for "All" genders.

Currently, there are NaN active trials in "Prairie Education and Research Cooperative". undefined are not yet recruiting, 9 are recruiting, 14 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Prairie Education and Research Cooperative, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Prairie Education and Research Cooperative, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 37 trials that are defined as “Not Applicable".

Prairie Education and Research Cooperative has several departments that took part in Clinical trials: "Central Illinois Diabetes and Clinical Research a Division of Prairie Education and Research Cooperative" - 3 trials